Intestinal dysbiosis is implicated in alcoholic hepatitis (AH). However, changes in the circulating microbiome, its association with the presence and severity of AH, and its functional relevance in AH is unknown. Qualitative and quantitative assessment of changes in the circulating microbiome were performed by sequencing bacterial DNA in subjects with moderate AH (MAH) (n 5 18) or severe AH (SAH) (n 5 19). These data were compared with heavy drinking controls (HDCs) without obvious liver disease (n 5 19) and non-alcohol-consuming controls (NACs, n 5 20). The data were related to endotoxin levels and markers of monocyte activation. Linear discriminant analysis effect size (LEfSe) analysis, inferred metagenomics, and predictive functional analysis using PICRUSt were performed. There was a significant increase in 16S copies/ng DNA both in MAH (P < 0.01) and SAH (P < 0.001) subjects. Compared with NACs, the relative abundance of phylum Bacteroidetes was significantly decreased in HDCs, MAH, and SAH (P < 0.001). In contrast, all alcohol-consuming groups had enrichment with Fusobacteria; this was greatest for HDCs and decreased progressively in MAH and SAH. Subjects with SAH had significantly higher endotoxemia (P 5 0.01). Compared with alcohol-consuming groups, predictive functional metagenomics indicated an enrichment of bacteria with genes related to methanogenesis and denitrification. Furthermore, both HDCs and SAH showed activation of a type III secretion system that has been linked to gram-negative bacterial virulence. Metagenomics in SAH versus NACs predicted increased isoprenoid synthesis via mevalonate and anthranilate degradation, known modulators of gram-positive bacterial growth and biofilm production, respectively. Conclusion: Heavy alcohol consumption appears to be the primary driver of changes in the circulating microbiome associated with a shift in its inferred metabolic functions. (HEPATOLOGY 2018;67:1284-1302.
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A lcohol-related liver disease remains a leading cause of morbidity and mortality in many parts of the world and has been linked to a decline in population survival in the United States. (1) (2) (3) The spectrum of liver disease associated with consumption of alcohol in harmful amounts includes a fatty liver to steatohepatitis with varying degrees of fibrosis to cirrhosis. (4) Although many patients with alcoholic steatohepatitis remain relatively asymptomatic, some individuals develop jaundice and worsening Abbreviations: AH, alcoholic hepatitis; CTP, Child-Turcotte-Pugh; DF, discriminant function; HDC, heavy drinking control; KO, KEGG orthologous; LDA, linear discriminant analysis; LEfSe, linear discriminant analysis effect size; MELD, Model for End-Stage Liver Disease; NAC, non-alcohol-consuming control; OTU, Operational Taxonomic Unit; MAH, moderate alcoholic hepatitis; rDNA, ribosomal DNA; SAH, severe alcoholic hepatitis; T3SS, type III secretion system; TREAT, Translational Research and Evolving Alcoholic Hepatitis Treatment.
liver function and present with the clinical syndrome of alcoholic hepatitis (AH), which was defined as described previously. (5) AH is a serious form of alcohol-induced liver disease and is a common cause for liver-related hospitalization and mortality. The risk of mortality is dependent on the severity of AH, which is usually assessed by the Maddrey's discriminant function (DF) or the Model for End-Stage Liver Disease (MELD) score. (6) Severe AH (MELD >20 or Maddrey's DF >32) is associated with a 20%-30% mortality in 4-6 weeks and up to 40% within 6 months. (7) (8) (9) Current therapies are only modestly effective in affected individuals, (10) underscoring the need to develop more effective preventive and therapeutic strategies against AH. This requires an indepth understanding of the pathogenesis of AH. Although much is now known about the mechanisms of disease development in AH, (11, 12) there are still gaps in knowledge, particularly related to why only some individuals at risk develop AH and what determines the severity of the disease.
Recently, the role of the microbiome has gained attention as a contributor to the development of alcohol associated liver disease. (13) Advances in molecular technology have identified the presence of microbiota in the circulation of healthy humans by sequencing 16S ribosomal DNA (rDNA) bacterial genes. (14) Although many changes in the intestinal microbiome in those who consume large amounts of alcohol as well as those with alcohol-induced liver disease (including changes in intestinal fungi) have been described along with increased intestinal permeability, endotoxemia, and activation of systemic inflammatory responses, (15) (16) (17) (18) (19) there are no data on the circulating microbiome in patients with AH. Changes in the blood microbiota and gut-microbiomebased metagenomics signature have recently been linked to liver fibrosis in obese patients and patients with nonalcoholic fatty liver disease (NAFLD). (20, 21) As a first step in elucidating the potential role of the circulating microbiome in AH, we measured the circulating microbiome in subjects with moderate AH (MAH) or severe AH (SAH) and compared it with control subjects who consumed large amounts of alcohol but did not have clinical evidence of liver disease and another group of control subjects without liver disease who did not consume alcohol. The specific aims of this study were to determine the qualitative and quantitative changes in the microbial populations and their associated metagenome in circulation with: 1) heavy alcohol consumption, 2) the presence of AH, 3) SAH versus MAH, heavy drinking controls (HDCs), and non-alcohol-consuming controls (NACs). We further related the changes in circulating microbiome to markers of monocyte activation and evaluated the interrelationship between circulating microbiome, markers of monocyte activation, and disease severity. We also evaluated the functional relevance of changes in the circulating microbiome using a predictive functional metagenomics approach in this wellcharacterized cohort of subjects who were recruited by the Translational Research and Evolving Alcoholic Hepatitis Treatment (TREAT) Consortium.
Materials and Methods
This study was a collaborative effort between investigators from the TREAT consortium. The TREAT consortium includes three clinical sites and a datacoordinating center and enrolls subjects in either a
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prospective registry (NCT02172898) or specific clinical trials for AH. Subjects with well-characterized AH (MAH and SAH) and controls (HDCs and NACs) were studied in this analysis. All subjects provided informed consent for these analyses, and the protocols were approved at each of the participating sites by their institutional review boards. The study was conceived, executed, analyzed, and written up by the investigators, all of whom take full responsibility for the contents of this manuscript.
STUDY COHORT
AH was defined by hyperbilirubinemia along with an elevated AST without alternate cause in an individual with a history of heavy alcohol consumption for at least 6 months and with the last alcoholic beverage consumed within 6 weeks of presentation, as reported recently. (5) Where there was diagnostic uncertainty, a liver biopsy was performed if clinically indicated to confirm the diagnosis. Subjects with a MELD score >20 were considered to have SAH, (6) whereas subjects with lower values were classified as having MAH. These subjects were compared with those HDC subjects who had normal levels of liver enzyme and bilirubin and no clinical findings suggestive of AH. The NAC group had no clinical, laboratory, or imaging evidence of liver disease. The exclusion criteria for this analysis included those with comorbid alternate etiologies of liver disease such as hepatitis C and clinically overt and active infection (positive cultures, chest x-ray showing pneumonia).
DATA COLLECTION AND CLINICAL EVALUATION
Demographic, medical history, and clinical data were collected. Alcohol drinking questionnaires to determine the quantity and pattern of alcohol consumption included the 10-question Alcohol Use Disorders Identification Test (AUDIT), the Time Line Follow-Back (TLFB), as well as the National Institute on Alcohol Abuse and Alcoholism's (NIAAA) sixquestion survey. Blood samples were collected for complete blood counts, metabolic panel, hepatic panel, and coagulation tests. The tests were performed at the local pathology and chemistry laboratory at each site. The MELD score, Child-Turcotte-Pugh (CTP) score, and Maddrey's DF were also recorded and patients were managed as clinically indicated based on the standard of care at each clinical center.
CIRCULATING MICROBIOME METHODOLOGY
Details regarding circulating microbiome methodology are provided in the Supporting Information. 
BIOINFORMATICS DATA PROCESSING AND STATISTICAL ANALYSIS
Linear discriminant analysis effect size (LEfSe) analysis was performed on the Operational Taxonomic Unit (OTU) table using the online Galaxy interface to identify bacterial taxa that were differentially abundant in groups. (22) Using the LEfSe algorithm, bacterial taxa that were differentially abundant in pairwise analysis for groups were first identified and tested using the Kruskal-Wallis test with adjustments for multiple comparisons (P < 0.05). Principal components analyses were also performed. The identified features were then subjected to the linear discriminant analysis (LDA) model with a threshold logarithmic LDA score set at 2.0 and ranked. Respective cladograms were generated with genus at the lowest level. Quantitative plots of differential features were generated from genus level percent relative abundance data showing means with standard deviation using GraphPad Prism 6 software. Specific correlations were performed using Spearman's coefficient. Venn diagrams were generated using the online tool jvenn. (23) Inferred metagenomics and predicted functional analysis was initiated by generating closed reference sequence clustering OTUs in QIIME. (24) The qualityfiltered, demultiplexed sequences were clustered by 97% similarity. Representative sequences were picked and aligned to the sequences from the Greengenes reference collection (gg_otus_13_5.tar.gz) to assign taxonomy.
The resulting OTU table was used to generate inferred metagenome data using the online Galaxy interface for Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt, version 1.0.0) with default settings as described. (25) Briefly, the abundance values of each OTU were normalized to their respective predicted 16S rRNA copy numbers and then multiplied by the respective predicted gene counts for metagenome prediction. The resulting core output was a list of Kyoto Encyclopedia of Genes and Genomes (KEGG) orthologues and predicted gene count data for each sample. We used inhouse scripts to parse the output into KEGG module categories for functional pathways and structural complex hierarchies using the KEGG database (http:// www.genome.jp/kegg/module.html). The output matrix containing the relative abundance of KEGG orthologous groups (KO) per sample was processed with the online Galaxy interface for LEfSe with a threshold logarithmic LDA score set at 2.0 and ranked. Respective cladograms were generated with modules at the lowest level. Quantitative plots of differential features were generated from normalized module level predicted gene data showing means with standard deviation. Pathway KO differential enrichment images were generated using KEGG Mapper (v2.8). (26) Results A total of 76 subjects (NACs, n 5 20; HDCs, n 5 19; MAH, n 5 18; SAH, n 5 19) were studied. The study groups were comparable for age and body mass index with male predominance among alcohol groups. The laboratory profile and severity of disease measures are described in Table 1 . As expected, when compared with NACs and HDCs, more pronounced anemia, leukocytosis, thrombocytopenia, abnormal hepatic panel, hyperbilirubinemia, hypoalbuminemia, and coagulopathy were seen in subjects with AH. Similarly, the MELD score, CTP score, and Maddrey's DF, all measures of disease severity, were highest in those with SAH.
FIG. 1.
Whole blood sample 16S rDNA sequence, diversity analysis, and relative taxonomic abundances. (A) Scatter plot depicting 16S copies/ngDNA among the study groups. There is a stepwise increase in 16S copies/ngDNA from NACs to HDCs to MAH to SAH. Compared with the NAC group, both MAH and SAH showed significantly higher 16S copies/ngDNA using the KruskalWallis test. (B) Stacked column bar graphs depicting the individual sample phylum level taxonomic abundance by study group for 16S targeted sequence analysis. Taxa were identified by name for the most abundant phyla or merged into the "Other" category for <0.5% abundance. (C) Plots of microbiome alpha diversity (Shannon index), representing the mean of species diversity per sample at the genus level with respect to alcohol use study groups, demonstrating a small but insignificant shift toward lower diversity in alcoholusing subjects and corresponding to disease severity. (D) Principal component analysis (PCoA) unsupervised dimensional reduction plots depicting the relationships between the microbiomes with respect to alcohol use study groups based on weighted UniFrac methodology for b diversity. (E) On partial least-square discriminant analysis, the study groups are separated by a supervised dimensionality reduction multivariate regression model. (F) Stacked column bar graphs depicting the average phylum level taxonomic abundance by study group for 16S targeted sequence analysis. Taxa were identified by name for the most abundant phyla or merged into the "Other" category for <0.5% abundance. Significantly lower relative abundance of the phylum Bacteroidetes was seen in the alcoholic groups (HDCs, MAH, SAH) versus the NACs using the Kruskal-Wallis test. 
ALCOHOL CONSUMPTION AND PRESENCE OF AH IS ASSOCIATED WITH INCREASED CIRCULATING BACTERIAL DNA
Measurement of circulating 16S copies/ng DNA revealed a stepwise increase from NAC to HDC to MAH to SAH (P < 0.01) (Fig. 1A) . Of note, compared with NACs, the mean 16S copies/ng DNA were significantly higher in both MAH (P < 0.01) and SAH (P < 0.001). These data demonstrate an increased circulating bacterial burden in subjects with MAH and SAH.
IMPACT OF ALCOHOL CONSUMPTION AND PRESENCE OF AH ON BACTERIAL DIVERSITY AND DISTRIBUTION OF MICROBIOTA IN CIRCULATION
A detailed illustration of the relative abundance of bacteria at a phylum level for individual groups is shown in Fig. 1B . The overall diversity of the microbiome, as assessed using the Shannon Diversity Index, (27) was not significantly different across the four study groups (Fig. 1C) . Furthermore, when principal component analysis was performed to compare samples based on the generalized UniFrac distance metrics with a 5 0.2 ( Fig. 1D) , no statistically significant differences were observed among the study groups. The relative bacterial abundance did, however, cluster separately (Fig. 1E) , and all alcohol-consuming groups had a statistically significant decrease in the relative abundance of the phylum Bacteroidetes (P < 0.0001) (Fig 1F) .
To further characterize the impact of alcohol consumption and presence of AH on the circulating microbiome, discriminative features cladograms ( Fig.  2A ) and abundance histograms (Fig. 2B) based on an effect size cutoff of 2.0 for the logarithmic LDA score were plotted. Compared with NACs, the circulating microbiome of subjects consuming alcohol (HDCs, MAH, and SAH combined) was significantly enriched with the obligate anaerobic, non-spore-forming, gram-negative bacilli phylum Fusobacteria and its subclasses Fusobacteriales and Leptotrichiaceae (Fig. 2A) . Interestingly, the degree of enrichment was greatest in HDCs, followed by MAH and then SAH (data not shown). Other gram-negative bacteria that were enriched in the alcohol-consuming groups (versus NACs) included Neisseriaceae, Chitinophagaceae, Bradyrhizobiaceae, and Peptostreptococcaceae ( Fig. 2A) . Alcohol-consuming groups were also enriched in gram-positive taxa, predominantly those under the phyla Actinobacteria (genus Turicella and Microbacterium) and Firmicutes (genus Anaerococcus, Lachnospiraceae incertae sedis, and Clostridium XI) (Fig. 2B) .
In addition, sex-based comparison of circulating microbiota was also performed. In the NAC group, Lachnospiraceae was enriched in males, whereas in the alcohol group (HDCs, MAH, and SAH) females were enriched in genus Actinomyces of phylum Actinobacteria and order Sphingomonadales and family Sphingomonadaceae belonging to the phylum Proteobacteria (Supporting Fig. S2A,B) .
ALCOHOL CONSUMPTION AND PRESENCE OF AH AFFECT BACTERIAL COMPOSITION WITHIN SPECIFIC PHYLA
The complex overlay of the differences in distribution of the microbiome across the study groups were next visualized using Venn diagrams (Fig. 3A) . Overall, NACs were enriched with 77 taxa compared with those consuming alcohol (Fig. 3A, panel 1, bar plot) , but only nine taxa had common enrichment when compared with all groups consuming alcohol (Fig. 3A,  panel 1, Venn diagram) . Conversely, the alcohol consuming groups were enriched in 43 taxa compared with the NACs (Fig. 3A, panel 2, bar plot) , but only four common taxa were enriched in alcohol groups (Fig. 3A, panel 2, Venn diagram) . The differential enrichment of specific bacteria at a family and genus level compared with NACs is shown in cladograms (Fig. 3B) and histograms, respectively (Fig. 3C) , based on an LDA score >2 for pairwise comparisons. Certain families were enriched in more than one alcohol group: Peptostreptococcaceae (HDCs, MAH and SAH), Leptotrichiaceae (HDCs and SAH), Bradyrhizobiaceae (HDCs, MAH and SAH), and Neisseriaceae (HDCs and SAH). Specific enrichment for individual alcohol groups compared with NACs included Streptomycetaceae (HDCs), Carnobacteriaceae, and Clostridiales Incertae Sedis XI (MAH); and Corynebacteriaceae, Dermabacteraceae, and Micromonosporaceae (SAH).
Within the Actinobacteria phylum, Nocardioides was uniformly enriched in the NACs compared with all other alcohol groups (Fig. 3C) . Specifically, enriched genus for different alcohol groups versus NAC group included Kocuria and Streptomyces (for HDCs), Actinomyces (for MAH), and Corynebacterium and Brachybacterium (for SAH).
Within the phylum Bacteroidetes, the NAC group was uniformly enriched in genus Prevotella and Flavobacterium when compared with all other alcohol groups (Fig. 3C) . Also, order Bacteroidales and families Porphyromonadaceae and Prevotellaceae were enriched in NACs versus all other alcohol groups. In contrast, compared with the NACs, each of the alcohol study groups was specifically enriched in a particular genus: Chryseobacterium (HDCs), Cloacibacterium (MAH), and Gillisia (SAH). For the phylum Firmicutes, subjects within the NAC group were enriched in Clostridium sensustricto compared with all alcohol consuming groups. The genus Anaerococcus and Clostridium XI were also enriched in all alcohol-consuming groups compared with the NACs. Within the phylum Fusobacteria, both HDC and SAH groups were enriched in the family Leptotrichiaceae, whereas only the SAH group was enriched with Leptotricha.
Within the phylum Proteobacteria (Fig. 3C) , Acinetobacter (OTU0021) was enriched in NACs versus all alcohol groups, whereas the genus Bradyrhizobium and Acinetobacter (OTU0019) were enriched in all alcohol groups versus the NAC group. On pairwise comparison, genus Phenylobacterium, Rhodobacter, and Neisseria were all enriched in HDCs versus NACs (Fig. 3C) . Also, both MAH and SAH were enriched with genus Methylobacterium and Curvibacter. Notably, SAH subjects compared with NACs were specifically enriched with genus Burkholderia and Cupriavidus.
DISTINCT CIRCULATING MICROBIOME ENRICHMENT IN ALCOHOLIC HEPATITIS
There were specific changes in the microbiome in subjects with AH compared with NACs. Whereas MAH was associated with enrichment of Coriobacteriaceae and Streptococcaceae, SAH was associated with enrichment of Dermabacteraceae and Micromonosporaceae (Fig. 4A) . As shown in the LDA > 2 histograms with pairwise comparisons, both AH groups were enriched with the genus Turicella and Curvibacter. Moderate AH and severe AH were also associated with specific enrichment of several genus compared with NACs (Fig. 4b) . Conversely, NACs showed specific enrichment of genus Microbacterium (versus MAH), and Rhodococcus, Hymenobacter, Roseomonas, and Janthinobacterium (versus SAH) (Fig. 4B) .
CIRCULATING MEASURES OF ENDOTOXEMIA AND MONOCYTE ACTIVATION IN ALCOHOLIC HEPATITIS
Plasma LPS levels (EU/mL) were significantly increased in SAH compared with HDCs (mean 6 standard deviation: HDCs, 0.039 6 0.007 versus MAH, 0.048 6 0.01 versus SAH, 0.051 6 0.01; P 5 0.01 HDCs versus SAH) (Supporting Fig. S1 ). However, no significant differences were seen in plasma LBP levels (lg/mL) among the alcohol consuming groups regardless of the presence and severity of AH (HDCs, 12.2 6 6.8 versus MAH, 11.3 6 5.5 versus SAH, 11.5 6 9.1). Also, no significant correlation between circulating 16S and LPS was observed (r 2 5 0.006, P 5 0.58). Soluble CD14 (sCD14) levels (lg/ mL) were higher and statistically significant (overall P 5 0.01) in subjects with MAH versus HDCs (2.6 6 0.8 versus 1.9 6 0.5; P 5 0.03) as well as versus SAH (1.9 6 0.8; P 5 0.04).
INTERRELATIONSHIPS OF DISEASE SEVERITY, MONOCYTE ACTIVATION, ENDOTOXEMIA, AND CIRCULATING MICROBIOME
Gram-negative Proteobacteria and gram-positive Firmicutes were inversely related in nondrinking controls (q 5 20.5; P 5 0.02). This relationship became more distinct in HDCs (q 5 20.84; P < 0.0001) and most notable in SAH (q 5 20.95; P < 0.0001).
Bacterial class Gammaproteobacteria and Betaproteobacteria were inversely correlated to MELD score, Maddrey's DF, and CTP score (q 5 20.47 to 20.67; P < 0.05 for all). Moreover, on regression analysis, the relative abundances of genus Janthinobacterium (P 5 0.02, r 5 20.30) was inversely related to the MELD score (Fig. 5) . Similarly, Enhydrobacter was also inversely related to the MELD score (r 5 20.29; P 5 0.03). However, neither LBP nor LPS were significantly correlated with either with disease severity scores (MELD, CTP, and DF) or stage of disease (HDCs, MAH, and SAH), suggesting that heavy alcohol use with and without AH potentially produced comparable endotoxemia.
The sCD14 levels were inversely correlated with MELD score (q 5 20.73 in MAH, P 5 0.0005; q 5 20.47 in SAH, P 5 0.04) and DF (q 5 20.76 in MAH, P 5 0.003). Whereas sCD14 was inversely correlated with Actinomycetales in HDCs and Coriobacteriales in SAH, plasma LBP was inversely correlated with Rhodobacterales in HDCs and Xanthomonadales in SAH (q 5 20.5 to 20.63, P < 0.05 for all).
FIG. 5.
Disease severity MELD regression plots. Regression analysis plots of 16S rDNA sequence relative abundance relative to MELD disease score. Two genera, Janthinobacterium and Enhydrobacter, from the phylum Proteobacteria were identified to have a negative correlation with MELD disease score. Blue: HDC; purple: MAH; red: SAH.
IMPACT OF ANTIBIOTIC USE ON CIRCULATING MICROBIOME
A total of 6/19, 10/18, and 14/19 subjects in the HDC, MAH, and SAH groups were on systemic antibiotics (P 5 0.03 for trend) at the time of sample collection even though there was no documented infection in these subjects at the time of sample collection. None of the NAC subjects had any recent (i.e., within 1 month) antibiotic use. Regardless of the group and the specific antibiotic used, those on antibiotics had an enrichment in BacteroidesBacteroideaceae while those without antibiotic exposure had an enrichment in Hymenobacter and Janthinobacterium. Importantly, the key findings distinguishing the changes in the circulating microbiome across groups FIG. 6 . Predicted metagenome metabolic pathway and structural complex analysis. LEfSe cladograms of pairwise analysis for the NACs and combined alcoholic groups (HDC 1 MAH 1 SAH) . The cladograms show the KEGG hierarchy for (A) metabolic pathways and (B) structural complexes represented by rings with the pathway or structural modules at the outermost ring, and each circle is a member within that level. KEGG modules are shaded green (NAC) or orange (alcoholics) according to level of alcohol use (LDA score >2.0; P < 0.05).
presented above were not altered by antibiotic exposure, with the exception of Janthinobacterium in the alcoholic hepatitis groups, where it was inversely related to MELD score. Furthermore, subjects with alcohol use and no antibiotic exposure (both HDCs and AH, as well as all alcohol groups combined) were compared with the NAC group. The principal findings in circulating microbiota composition were similar to the original overall cohort (subjects with and without antibiotic exposure) (Supporting Fig. 3A,B) . 
FUNCTIONAL CIRCULATING METAGENOME IN ALCOHOL CONSUMING SUBJECTS
Inferred metagenomics analysis using PICRUSt was performed to predict the functional potential of the circulating metagenome in relation to the alcohol consumption and presence of AH. First, the NAC group when compared with heavy alcoholics (HDCs, MAH, and SAH) had markedly enriched metabolic pathways containing gene functions such as methanogenesis, denitrification, citrate cycle, glucuronate/uronate and glycosaminoglycan metabolism including keratan sulfate degradation (Fig. 6A) . In contrast, heavy alcoholics (HDCs, MAH, and SAH) compared with NACs, were enriched for genes of structural components of the type III secretion system (T3SS) (Fig. 6B) . Similarly, functional metagenomics predicted that lysine, arginine, ornithine, methionine, and histidine transport systems were activated in heavy alcoholics (HDCs, MAH, and SAH) (Fig. 6B) .
Next, we compared SAH versus NAC groups. Interestingly, SAH subjects had markedly enhanced isoprenoid biosynthesis via mevalonate pathway compared with non-mevalonate pathway in NACs (Fig. 7A) . Also, in SAH, other notable metabolic pathways that were predictably enhanced included anthranilate degradation pathway, which is associated with bacterial biofilm formation, and ketone body biosynthesis among others (Fig. 7A) . Furthermore, the SAH group was enriched with bacterial community associated with hemophore metalloprotease, vitamin B12, phosphonate transport systems, and T3SS, among other amino acid transport systems (Fig. 7B) .
Discussion
There is growing appreciation that the human body represents a complex ecosystem wherein the host lives in a symbiotic relationship with resident microbiota. Perturbations in the microbiome are associated with multiple disease states. While numerous studies have documented such changes in the intestinal microbiome in those with liver disease related to alcohol use, the changes in the circulating microbiome were not known previously. The current study indicates that there are indeed multiple changes in the circulating microbiome, both in heavy alcohol consumers without overt liver disease and with AH. More importantly, these changes are associated with shift in the metabolic functions of the circulating microbiome.
A key finding from this study is the decrease in the blood-borne signature of relative abundance of the phylum Bacteroidetes in all groups consuming alcohol compared with NACs. Previously, a variable increase in fecal Bacteroidetes was reported in relation to alcohol use disorders, and a more consistent increase was noted in NAFLD. (28) (29) (30) Of note, the previously reported increase in Proteobacteria in subjects with heavy alcohol consumption (fecal and mucosal) and subjects with NAFLD (18, 31, 32) was not observed in the circulating microbiome in alcohol-consuming subjects in this study. The relationship and cross-talk between the fecal microbiome and the circulating microbiome is a largely unexplored area of research and modulation of circulating microbial signatures are likely to be multifactorial in origin. These could include changes in diet, intestinal microbiota, altered gut barrier function, and gut-based immune responses. The current data set the stage for hypothesis generation and future mechanistic studies in the context of AH.
Previous studies have noted an increase in Fusobacteria in feces of individuals with cirrhosis, including alcohol-induced cirrhosis. (33) Furthermore, an enrichment with Fusobacteria was noted in those with overt hepatic encephalopathy. (34) This had led to the concept that they may directly influence the development of this cirrhosis-related complication. The current data extend the observation of increased Fusobacteria in stool of those with cirrhosis to the circulation. We observed that it is enriched in even the HDCs and that the development and severity of AH was inversely related to the degree of enrichment with Fusobacteria. We thus hypothesize that this inverse relationship may reflect the protective value of increased Fusobacteria in individuals who consume large amounts of alcohol and that a failure to increase these bacteria allows liver disease to develop and increase in severity. This hypothesis needs to be validated in appropriately designed studies.
A key challenge in evaluating the potential role of the circulating microbiome in health and disease is that specific bacteria cannot be removed or added to circulation to see their impact on specific physiological processes. Furthermore, the circulating microbiome signature is present in healthy hosts and does not represent an immune deficiency or infection in the traditional sense. The mechanisms by which they establish a symbiotic relationship with the host immune system also remains largely unknown. The development of specific methodology to evaluate gain or loss of function of the microbiota is now a major unmet need to fully leverage the observed changes in the circulating microbiome to improve human health.
Until such methods are developed, analytic tools such as inferred metagenomics can be used to assess the potential impact of changes in bacterial relative abundance on the functionality of the microbiome. In this study, such analyses indicated that the circulating microbiome of NACs were enriched with respect to methanogenesis, denitrification, and several other functions. A growing body of literature indicates an important role of gases as "signaling" molecules, and both methane and hydrogen sulfide have been implicated as regulators of intestinal epithelial integrity and gut-derived inflammatory signals. (35, 36) A likely possibility is that circulating bacteria, by producing even minute quantities of such gases, and/or pathogen-associated molecular patterns may modulate signaling within the innate and adaptive immune system, modify oxidative stress, and affect the microcirculation and even cellular function in individual organs. This possibility is further supported by the well-established roles of nitric oxide and carbon monoxide as modulators of endothelial dysfunction, microcirculation, organ function, and inflammation, particularly in the liver. (37) (38) (39) (40) Another noteworthy finding is that the functional metagenome shows enrichment of genes for structural components of the T3SS in HDCs and SAH. This finding is highly relevant, because the T3SS machinery is uniquely related to the pathogenicity of gramnegative bacteria. The T3SS apparatus consists of a needle-like injectisome complex (41) that promotes virulence by translocating effector proteins into host cells, where they exert antihost effects such as facilitated invasion, intracellular survival, phagocytic avoidance, and disruption of host defenses. (42) This could explain one of the mechanisms of increased risk of gramnegative pathogens in patients with heavy alcohol use and SAH.
Also noteworthy is isoprenoid biosynthesis pathway on functional metagenome. Isoprenoids are vital for the growth and survival of prokaryotes, supporting core functions such as cell wall and membrane synthesis and aerobic respiration, among others. (43) Enhanced isoprenoid biosynthesis via the mevalonate pathway, mainly seen in gram-positive pathogens, (44) may contribute to the risk of gram-positive pathogen infection in SAH. In fact, gram-positive Enterococcus emerged as the most frequent cause of infection in SAH patients. (45) Notably, in patients with SAH there is shift in function of circulating microbiota with enrichment of the anthranilate degradation pathway. This pathway is significant in forming bacterial biofilm, as shown previously. (46) Bacterial biofilm also contributes to the pathogenesis and antibiotic/host immune resistance to a number of medically important bacterial strains (47) and likely plays an important role in infections associated with patients with SAH. Together, these findings on functional aspects of circulating microbiome provide direction for future research and could potentially lead to the development of novel therapeutic approaches.
Heavy alcohol consumption has been linked to endotoxemia, (48) and endotoxin load is widely believed to represent a key pathophysiological step in the genesis of AH. The current data also support a role for factors beyond endotoxemia in the genesis of AH and thus extend the existing paradigm. It is also interesting to note the inverse relationship between sCD14, a marker of monocyte activation through TLR4, and the severity of AH. Theoretically, this could be due to immunosuppression associated with SAH; the current data provide the rationale for testing this hypothesis in the future.
The current study does have some limitations that need to be considered in evaluating the data. The control groups did not have a liver biopsy for logistical and ethical considerations, thus the possibility of clinically unapparent disease cannot be excluded completely. This possibility was minimized, however, by selecting asymptomatic individuals with normal liver enzymes and hepatic function. The diagnosis of AH was also based on clinical criteria without mandatory requirement of liver biopsy, and one could question whether some of these individuals had alternate diagnoses, as has been suggested by others. (49, 50) We believe that the probability of our subjects not having AH is low because sepsis leading to decompensated cirrhosis, a key diagnostic confounder, was carefully excluded in all cases. Furthermore, alternate causes of liver disease (e.g., viral hepatitis) were excluded in all individuals. However, it is possible and indeed probable that many of the subjects had AH superimposed on cirrhosis, as has been observed previously. While the use of antibiotics alter the circulating microbiome, they did not impact the principal differences between the study groups. Therefore, the findings reflect the changes in those with AH in a "real world" setting, which usually include AH superimposed on cirrhosis rather than pure AH. Also, the effects of diet, previous exposure to antibiotics, and correlation with concomitant gut microbiome could not be derived due of lack of these data in the present study, and their relationship merits further exploration by specifically designed studies in the future. Also, we used a MELD score of >20 to define SAH, which has less variability than DF, as reported previously. (6) Thus, there is a small potential for obtaining somewhat different data if the thresholds to separate MAH versus SAH were based on the DF.
Much work remains to be done to better understand the physiological and pathophysiological functions of the circulating microbiome. The current study provides a description of the compositional changes associated with AH and shift in the metabolic functions of circulating microbiota. These provide the foundational basis for future focused studies on the role of the circulating microbiome and its related metabolites in the genesis of alcohol-associated liver disease.
